InvestmentPitch Media Video Discusses FSD Pharma's Termination of its CEO, Dr. Raza Bokhari, for Cause - Video Available on Investmentpitch.com

About this update from Quantum Biopharma Ltd. Subordinate Voting Shares Class B

[{"type":"text","content":"InvestmentPitch Media Video Discusses FSD Pharma's Termination of its CEO, Dr. Raza Bokhari, for Cause - Video Available on Investmentpitch.comVancouver, British Columbia--(Newsfile Corp. - July 28, 2021) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A), a specialty, biotech pharmaceutical R&D company, has terminated its CEO, Dr. Raza Bokhari, for cause. Following the company's shareholder meeting on May 14, 2021, Dr. Raza Bokhari was placed on administrative leave while a special committee comprised of two independent directors investigated various concerns regarding Dr. Bokhari's actions in his capacity as CEO.InvestmentPitch.com has produced a \"video\" which discusses this news. If this link is not enabled, please visit www.InvestmentPitch.com and enter \"FSD Pharma\" in the search box.Cannot view this video? Visit:http://www.investmentpitch.com/video/1_2lwpshwh/FSD-Pharma-a-specialty-biotech-pharmaceutical-RD-company-has-terminated-its-CEO-Dr-Raza-Bokhari-for-causeAn international law firm was engaged as independent legal advisors, and based on its investigation, the special committee recommended to the company's board of directors and the board unanimously determined to terminate Dr. Bokhari's employment for cause. As stated in the company's news release: \"Amongst several findings made by the special committee and the international law firm, only a few of the reasons for Dr. Bokhari's termination are misconduct including breaching court orders, the improper issuance of shares, and attempts to misappropriate company funds in breach of his employment obligations.\" Anthony Durkacz, Zeeshan Saeed and Donal Carroll, directors who have been named by Dr. Bokhari in litigation, abstained from voting on the matter.Anthony Durkacz, Interim CEO, stated: \"The Company now has the benefit of a strong board of directors who bring with them highly-relevant experience and knowledge. I look forward to continue working with them to restore FSD and realize its full potential.\"Zeeshan Saeed, President, added: \"As we move forward, we look forward to providing further updates to shareholders in the coming weeks. We remain committed to fulfilling all of the strategic and operational goals outlined in our communications to shareholders prior to the May 14, 2021 shareholder meeting.\"Messrs. Durkacz and Saeed noted the pr...

More updates from Quantum Biopharma Ltd. Subordinate Voting Shares Class B